Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study
about
Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infectionEndophthalmitis following open-globe injuriesEndophthalmitis: Pathogenesis, clinical presentation, management, and perspectivesRole of TLR5 and flagella in bacillus intraocular infection.Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, antibiotic susceptibility, and outcomes.Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.Antibiotic therapy in post-operative endophthalmitis.Intravitreal dexamethasone in the management of delayed-onset bleb-associated endophthalmitisOutcome of endophthalmitis treatment in a tertiary referral center in southern iran.Current management strategies of acute post-operative endophthalmitis.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Toward improving therapeutic regimens for Bacillus endophthalmitis.Intravitreal daptomycin: a safety and efficacy studyComparison of clinico-microbiological profile and treatment outcome of in-house and referred post cataract surgery endophthalmitis in a tertiary care center in South India.Evidence for and against intravitreous corticosteroids in addition to intravitreous antibiotics for acute endophthalmitis.Role of inflammation in endophthalmitis.Ocular Infection: EndophthalmitisModeling intraocular bacterial infections.CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection.Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgerySevere bacterial endophthalmitis: towards improving clinical outcomesA prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results.Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.An in vitro study on the compatibility and concentrations of combinations of vancomycin, amikacin, and dexamethasone in human vitreous.Redefining evidence in the management of acute post-cataract surgery endophthalmitis in India - The 2014 Adenwalla Oration, All India Ophthalmological Society.A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics.Clinical Outcomes of Adjunctive Sustained-Release Intravitreal Dexamethasone Implants in Tuberculosis-Associated Multifocal Serpigenoid Choroiditis.
P2860
Q26998053-9AB8B547-ACF0-4407-94A8-766C45469893Q27002960-1AC24802-E219-4930-A0BE-6CB9D8079A57Q33774225-BE4E09BA-A0CA-45F7-B739-588C8E15286DQ33799956-53FE1D0E-85FE-412D-AD03-2997B0008EA6Q33906155-5FF2AC01-F2C1-409C-9581-32234891DCC2Q34090101-0E89A5F6-39FC-4561-8AAD-BBA7BB985342Q34123551-788B99CA-F5BE-41D1-9332-EBEDA47877D3Q34551772-6F60A1C6-3C6B-4414-ADEC-55FD5D662487Q35132369-46F94848-33E8-4AB5-B205-C2C15DE61AC7Q35687473-722DF87F-F7B4-4F1E-A504-0A331AD0C380Q35749352-FDB5D5E8-1929-4329-81D2-75D55894918DQ35932531-CC956CB5-16E9-4294-B762-CD009155DA21Q36441711-1ECDE19B-4B89-4878-8972-3F82E5CE1C03Q36866018-40EA63B7-25FF-4A92-AF97-0DBFAF4E71C1Q37183015-6C0E9C11-5DAB-4E27-B5CC-85624BC7830EQ37433384-6253AE8E-5FCB-459D-91AE-90EE134D79F9Q37706964-5CA3531C-4245-41B3-8EB1-A627869547C5Q38042909-7319998E-5D13-4607-966A-75DF9A5D3ACBQ38616486-DFFFAE38-39A2-4941-BAED-A47AE1DF8FC9Q38827899-E29C19E7-21D8-49FF-B4BE-0DC4658837B2Q40473896-CEB13950-250C-4C22-A916-F20139515E1CQ41352760-4AD94DDD-A2E7-449E-82B3-2CC8BBF504EFQ41908007-579C8867-8811-40C5-A2A1-0D35A4FD5226Q44464192-F0066A47-621F-45CA-BECB-FBDBF7E290ECQ46121000-AF85DEC3-A912-4216-851A-D699E94EE04BQ46987146-C21F1004-945F-4B0D-84E6-1C05C91122D1Q47154791-5A22B0EC-C058-4290-96CF-3028CB9DD0D4Q48161923-3158E55A-DA1C-4C9E-B37E-FE1001B37E82Q50094390-E58E346D-0909-46E7-9C52-5E8874FD4FF1
P2860
Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Intravitreal dexamethasone in ...... a prospective randomised study
@ast
Intravitreal dexamethasone in ...... a prospective randomised study
@en
type
label
Intravitreal dexamethasone in ...... a prospective randomised study
@ast
Intravitreal dexamethasone in ...... a prospective randomised study
@en
prefLabel
Intravitreal dexamethasone in ...... a prospective randomised study
@ast
Intravitreal dexamethasone in ...... a prospective randomised study
@en
P2093
P2860
P356
P1476
Intravitreal dexamethasone in ...... a prospective randomised study
@en
P2093
P2860
P304
P356
10.1136/BJO.83.9.1050
P407
P577
1999-09-01T00:00:00Z